Patients 2025 predictions and AI trends for pharma executives The role of technology – particularly artificial intelligence (AI) – is top of mind for pharma executives this year (if it isn’t already).
Patients Tackling inappropriate prescription practices for weight los... A critical issue within the pharmaceutical sector has been highlighted by the MHRA’s investigation into the improper prescription of Wegovy.
Patients Four key trends and innovations catalysing infusion therapy ... IV treatment is one of the most traditionalist and wide-spread treatments provided to the 90% of hospitalised patients, yet, recent supply challenges like the
Patients Caring for the caregivers: Using data to strengthen HCP enga... Healthcare providers (HCPs) stand at the heart of patient care, tirelessly working to support, engage, and advocate for their patients.
Patients Health literacy matters: 3 ways to improve patient understan... Every day, thousands worldwide find out they have a disease or health condition that requires care.
Patients 3 ways AI and patient-centred support can improve medication... Healthcare is transitioning to a patient-centric approach and healthcare consumerism.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.